Research Topics
Species | Andreas SkolarikosSummaryAffiliation: University of Athens Country: Greece Publications
| Collaborators
|
Detail Information
Publications
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology GroupA Bamias
Oncology Department, Ioannina University Hospital, Ioannina, Greece
Oncology 64:102-10. 2003..We conducted a randomized, open label study to assess the efficacy of erythropoietin in preventing transfusions and significant anemia (hemoglobin <10 g/dl) in patients with solid tumors receiving platinum-based chemotherapy...
Angiogenesis: a promising therapeutic target for ovarian cancerA Bamias
Dept of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Crit Rev Oncol Hematol 84:314-26. 2012..Apart from VEGF, PDGF, FGF and angiopoietins present a therapeutic interest. We are reviewing the results of published clinical studies using anti-angiogenic factors in advanced ovarian cancer...
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factorA Bamias
Dept of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Eur J Cancer 48:1476-83. 2012..Ovarian carcinomas have been classified into types I and II according to the hypothesised mode of carcinogenesis and molecular characteristics. The prognostic significance of this classification has not been studied...
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcomeAristotle Bamias
Department of Clinical Therapeutics, University of Athens, Athens, Greece
Oncology 81:365-71. 2011..We investigated the efficacy of risk-adapted adjuvant paclitaxel/carboplatin chemotherapy in early-stage ovarian carcinoma...
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group studyChristos A Papadimitriou
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece
BMC Med 9:10. 2011..In this multicenter adjuvant phase III trial, we evaluated the addition of irinotecan to weekly 5FU plus LV in patients with stage II or III colon cancer...
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology GroupAristotelis Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Urol Oncol 29:189-93. 2011..Certain factors are used to select patients in high-risk for relapse. We report the outcome and safety of a risk-adapted strategy by the Hellenic Cooperative Oncology Group...
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic studyAristotle Bamias
Oncology Department, Ioannina University Hospital, Ioannina, Greece
Am J Clin Oncol 27:465-71. 2004..Objective response rate in 23 evaluable patients was 39.2%. The combination of LV5FU2 with bimonthly 90 mg/m2 cisplatin is feasible and active and should be further evaluated in patients with advanced gastric cancer...
Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experienceAristotle Bamias
Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece
Eur Urol 53:323-31. 2008..To investigate potential prognostic and predictive factors in patients with androgen-independent prostate cancer (AIPC) treated with docetaxel chemotherapy...
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapyA Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, 31 Komninon Street, Haidari, 12462 Athens, Greece
Ann Oncol 16:307-13. 2005..We compared the tolerability and efficacy of first-line platinum (cisplatin or carboplatin)-based chemotherapy in elderly patients (> or =70 years) with those in younger patients...
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology GroupAristotle Bamias
Department of Clinical Therapeutics, Athens University, School of Medicine, Athens, Greece
Cancer 106:297-303. 2006..The objective of the current multicenter Phase II study was to evaluate the safety and efficacy of the combination of gemcitabine and carboplatin as first-line treatment in unselected patients with advanced urothelial carcinoma...
Microvessel density (MVD) and cyclooxygenase-2 (COX-2)/ beta-catenin interaction are associated with relapse in patients with transitional carcinoma receiving adjuvant chemotherapy with paclitaxel/carboplatin: a hellenic cooperative oncology group (HECOG)A Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Greece
Anticancer Res 28:2479-86. 2008..Cycloxygenase (COX)-2 has been associated with proliferation, apoptosis and angiogenesis in urothelial cancer. The prognostic significance of COX-2 in patients who received adjuvant chemotherapy for urothelial cancer was examined...
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors modelAristotelis Bamias
Department of Clinical Therapeutics, Athens University, Medical School, Athens, Greece
BMC Cancer 10:45. 2010..We studied the prognostic significance of baseline characteristics and we compared the risk stratification with the established Memorial Sloan Kettering Cancer Center (MSKCC) model...
Neoadjuvant chemotherapy in invasive bladder cancerAristotle Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Haidari, 124 62 Athens, Greece
Expert Rev Anticancer Ther 5:993-1000. 2005..Finally, issues of improving therapeutic efficacy and directing clinical research are discussed...
Systemic chemotherapy in inoperable or metastatic bladder cancerA Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Greece
Ann Oncol 17:553-61. 2006..The true role of such therapies is currently being evaluated...
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapyAristotelis Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Greece
Gynecol Oncol 108:421-7. 2008..We have investigated the association of cytokines in the ascites from patients with ovarian cancer with these populations, the platinum resistance and the prognosis of these patients...
Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studiesAristotle Bamias
Dept of Clinical Therapeutics, Medical School, University of Athens, Greece
Int J Gastrointest Cancer 36:29-38. 2005..We are presenting a pooled analysis of prognostic factors from two randomized studies of adjuvant treatment conducted by the Hellenic Cooperative Oncology Group...
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessmentAristotle Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Oncology 73:290-7. 2007..We evaluated safety and efficacy of first-line gemcitabine/carboplatin in unfit-for-cisplatin patients with advanced urothelial carcinoma and the effect on the quality of life and functional status of elderly patients (aged >70)...
Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancerAristotle Bamias
Department of Clinical Therapeutics, University of Athens, Medical School, Athens, Greece
Eur Urol 52:1113-4. 2007
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistanceA Bamias
Department of Clinical Therapeutics, University of Athens, Greece
Gynecol Oncol 106:75-81. 2007..We performed a prospective study of T lymphocytes isolated from ascites from patients with ovarian carcinoma and we compared them with the respective populations in blood and tumors...
Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancerA Bamias
Oncology Dept, Ioannina University Hospital, Ioannina, Greece
J Chemother 15:275-81. 2003..It may represent an attractive option in patients at high risk for developing specific irinotecan toxicity...
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experienceA Bamias
Department of Clinical Therapeutics, University of Athens, Athens, Greece
Gynecol Oncol 123:37-42. 2011..Early-stage epithelial ovarian cancer represents a prognostically heterogenous group. We studied prognostic factors in patients treated with adjuvant paclitaxel/carboplatin chemotherapy...
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancerA Bamias
Department of Clinical Therapeutics, University of Athens, Medical School, Greece
Eur J Cancer 47:1660-8. 2011....
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology GroupA Bamias
Department of Clinical Therapeutics Urology, Hygiene and Epidemiology, University of Athens School of Medicine, Athens, Greece
J Clin Oncol 22:220-8. 2004..The toxicity of this regimen compared favorably with that reported for MVAC. We thus designed a randomized phase III trial to compare DC with MVAC...
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology GroupAristotle Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
BMC Cancer 6:228. 2006..Surgery can cure a significant percentage of ovarian carcinoma confined to the pelvis. Nevertheless, there is still a 10-50% recurrence rate. We administered paclitaxel/carboplatin as adjuvant treatment in early-stage ovarian carcinoma...
Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology GroupAristotelis Bamias
Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece
Urology 70:1179-83. 2007..Although cure is the rule, relapses still occur, especially in high-risk populations. We report the results of a risk-adapted strategy by the Hellenic Cooperative Oncology Group...
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancerAristotelis Bamias
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
Cancer Chemother Pharmacol 65:1009-21. 2010..However, the possibility that a benefit by the addition of RT was not detected due to decreased power of the study should not be excluded...
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology GroupA Bamias
Department of Clinical TherapeuticsUniversity of Athens, School of Medicine, Athens, Greece
J Clin Oncol 22:2150-4. 2004..We prospectively studied a cohort of patients who underwent surgery for high-risk carcinoma of the upper urinary tract to assess the feasibility of the combination of paclitaxel and carboplatin as adjuvant treatment...
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapyAristotle Bamias
Department of Therapeutics, University of Athens Medical School, Athens, Greece
Cancer 116:1462-8. 2010..The authors compared the outcome of these subtypes with that of serous tumors in patients who were treated with combination paclitaxel/platinum at their center...
Diagnosis and management of hypertension in advanced renal cell carcinoma: prospective evaluation of an algorithm in patients treated with sunitinibA Bamias
Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece
J Chemother 21:347-50. 2009..The application of such protocols instead of commonly used toxicity criteria should be further validated...
Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term resultsA Bamias
Department of Clinical Therapeutics, University of Athens, School of Medicine, Greece
Eur Urol 46:344-50; discussion 350-1. 2004..We are reporting the results of a phase II study using this combination as neoadjuvant treatment in patients with muscle invasive bladder cancer...
Editorial comment on: new treatment approaches for prostate cancer based on peptide analoguesAristotelis Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Eur Urol 53:899-900. 2008
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter studyMeletios A Dimopoulos
Departments of Clinical Therapeutics, Obstetrics and Gynecology, University of Athens School of Medicine, 31 Komninon Street, Haidari 124 62, Athens, Greece
Gynecol Oncol 95:695-700. 2004..CONCLUSION: The modified 3-day BEP regimen was safe and effective in patients with OGCT. Further improvements are needed for patients with advanced, suboptimally debulked non-dysgerminomatous tumors...
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experienceGeorge Bozas
Department of Clinical Therapeutics, School of Medicine, University of Athens, Athens, Greece
Oncology 70:265-72. 2006..The survival advantage of young patients may be attributed to the association with low tumor grade, more complete surgical debulking and better performance status...
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinomaGeorge Bozas
Department of Clinical Therapeutics, University of Athens, Medical School, 31 Komninon St, Haidari, 12462 Athens, Greece
Gynecol Oncol 104:580-5. 2007..Synergism between gemcitabine and cisplatin is supported by preclinical and clinical data. The present study explores the efficacy of a biweekly regimen in platinum-resistant/refractory, paclitaxel-pretreated ovarian and peritoneal cancer...
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessmentE Efstathiou
Department of Clinical Therapeutics, University of Athens School of Medicine, Haidari, Athens, Greece
Urology 65:126-30. 2005..CONCLUSIONS: The combination of an every-2-week regimen of docetaxel, EMP, and zoledronic acid is an effective, well-tolerated regimen that results in symptomatic improvement in a significant proportion of patients with AIPC...
Upper urinary tract transitional cell carcinoma. A 10-year experienceAthanasios G Papatsoris
Second Department of Urology School of Medicine, University of Athens, Sismanoglio Hospital, Athens, Greece
Tumori 94:75-8. 2008..To present our 10-year experience with patients surgically treated for upper urinary tract transitional cell carcinoma...
Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)Iraklis C Mitsogiannis
University of Athens, School of Medicine, 2nd Department of Urology, 5 Proussis Street, 14232 Nea Ionia, Athens, Greece
Expert Opin Pharmacother 10:493-501. 2009..In view of these promising results, large-scale, randomized, controlled trials are warranted to clearly define the exact role of lanreotide and other somatostatin analogs in the treatment of patients with CRPC...
Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?Andreas Skolarikos
First Department of Urology, University of Athens, School of Medicine, Athens, Greece
Int J Urol 12:563-9. 2005..The aim of the present study was to correlate bcl-2 protein expression and DNA-ploidy status with established prognostic parameters in renal cell carcinoma (RCC) and to examine their impact on disease progression and patient survival...
The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapyEfstathios Kastritis
Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Anticancer Res 26:3865-9. 2006..Well-known prognostic factors in transitional cell carcinomas were also associated with prognosis in mixed carcinomas...
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapyE Kastritis
University of Athens, Department of Clinical Therapeutics, Alexandra Hospital, 31 Komninon St, Haidari, 124 62, Athens, Greece
Gynecol Oncol 104:372-6. 2007..It is unknown whether these young patients have a poorer outcome compared to older patients or whether elderly patients have inferior outcome than younger patients when treated with combination chemotherapy...
A review on follow-up strategies for renal cell carcinoma after nephrectomyAndreas Skolarikos
Athens Medical School, 2nd Department of Urology, Sismanoglio Hopsital, Athens, Greece
Eur Urol 51:1490-500; discussion 1501. 2007..To provide a comprehensive review of the evidence supporting the necessity for follow-up after nephrectomy for renal cell carcinoma...
Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?Andreas Skolarikos
2nd Department of Urology, School of Medicine, University of Athens, Sismanoglio General Hospital Athens, Greece
J Urol 173:1908-11. 2005..We also defined potential risk factors for extravesical recurrence prospectively giving emphasis to the management of the perforation...
Use of nonsteroidal anti-inflammatory drugs after radical retropubic prostatectomy: a prospective, randomized trialEvangelos M Mazaris
2nd Department of Urology, University of Athens, Sismanoglio Hospital, Agia Paraskevi, Athens, Greece
Urology 72:1293-7. 2008..To assess the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) administered after radical retropubic prostatectomy (RRP)...
Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective studyGerasimos Alivizatos
Athens Medical School, 2nd Department of Urology, Sismanoglio Hospital, Athens, Greece
Eur Urol 54:427-37. 2008..To compare the effectiveness and the safety of photoselective vaporization of the prostate (PVP) to open prostatectomy (OP) for the surgical treatment of large prostatic adenomas...
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacinGeorgios Chamilos
Department of Clinical Therapeutics, University of Athens Medical School, Athens, Greece
Cancer 103:2629-35. 2005..Nevertheless, to the authors' knowledge, the best antibiotic regimen and the feasibility of ambulatory treatment have not been clearly defined...
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology GroupN Xiros
Second Department of Internal Medicine, Propaedeutic and Research Institute, University General Hospital Attikon, University of Athens, Greece
Ann Oncol 16:773-9. 2005..In the present phase II multicenter study, we assessed the efficacy and tolerability of the combination of gemcitabine and carboplatin in patients with advanced pancreatic cancer...
The novel prostate cancer antigen 3 (PCA3) biomarkerAndreas Bourdoumis
University Department of Urology, Sismanoglio Hospital, Athens, Greece
Int Braz J Urol 36:665-8; discussion 669. 2010..Results from relevant clinical studies, comparative with PSA, are warranted in order to confirm the perspective of PCA3 to substitute PSA...
Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implicationEfstathios Kastritis
Department of Clinical Therapeutics, Athens University, School of Medicine, Athens, Greece
Int J Cancer 124:103-8. 2009..Further study of the role of the Wnt pathway, potential crosstalk with other pathways and potential candidate therapeutic targets in urothelial cancer is needed...
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factorsAristotle Bamias
Department of Clinical Therapeutics, Medical School, University of Athens, Greece
J Clin Oncol 23:8580-7. 2005..Length of exposure seems to be the most important risk factor for this complication. The type of bisphosphonate may play a role and previous dental procedures may be a precipitating factor...
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agentsEfstathios Kastritis
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, School of Medicine, Athens, Greece
Haematologica 92:546-9. 2007..046). In conclusion, RF is reversible in the majority of newly diagnosed MM patients treated with high-dose dexamethasone containing regimens. The addition of novel agents induces a more rapid RF reversal...
A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinomaH P Kalofonos
Hellenic Cooperative Oncology Group HeCoG, Data Office, Athens, Greece
Cancer Invest 21:855-62. 2003..Further studies are needed to compare the present regimen with higher doses of CPT-11 with LV plus different schedules of 5-FU administration in the treatment of metastatic CRC...
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterusG T Bozas
Department of Clinical Therapeutics, University of Athens, Alexandra Hospital, Greece
Eur J Gynaecol Oncol 26:627-31. 2005..The most frequent grade 3-4 toxicity was neutropenia. CONCLUSION: Chemotherapy with paclitaxel plus carboplatin is feasible and possibly prevents distant metastasis when used as adjuvant in UPSC and UCCC...
Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?Theocharis Karaolides
Anticancer Hospital Agios Sabas, Athens, Greece
Urology 80:354-9. 2012..To evaluate the effect of hexaminolevulinate (HAL)-induced fluorescence during resection of noninvasive bladder cancer on tumor recurrence compared with resection under white light...
Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experienceAndreas Skolarikos
Second Department of Urology, University of Athens School of Medicine, Sismanoglio General Hospital, Athens, Greece
Urology 68:495-9. 2006..To assess the safety, feasibility, and effectiveness of percutaneous nephrostomy tube (PNT) insertion performed solely by a urologist on an outpatient basis. We present our relevant 10-year experience...
Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomyCharalambos Deliveliotis
2nd Department of Urology, University of Athens Medical School, Sismanoglion Hospital, 4 Monis Petraki Street, 11521, Kolonaki, Athens, Greece
World J Urol 25:309-13. 2007..TRUS-guided biopsy is an efficient tool in detecting local recurrence after RP and should be offered to all patients with biochemical relapse and absence of metastatic disease irrespective of the level of PSA...
Prostate cancer with metastasis to the omentum and massive ascites: a rare manifestation of a common diseaseFlora Zagouri
Department of Clinical Therapeutics, Athens University, School of Medicine, Athens, Greece
Onkologie 32:758-61. 2009..The most common sites of metastasis in prostate cancer include bone and regional lymph nodes followed by lung, liver, and brain. Peritoneal metastasis without skeletal involvement is extremely rare...
Unreliable residual volume measurement after increased water load diuresisGerasimos Alivizatos
Second Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece
Int J Urol 11:1078-81. 2004..The aim of the present study was to examine whether increased water load intake prior to ultrasound examination of the lower urinary tract, affects the measurement of postvoid residual urine volume...
Management of advanced bladder cancer in patients with impaired renal functionEvangelos Bournakis
Department of Clinical Therapeutics, Medical School, University of Athens, 80 Vasilissis Sofias Ave, Athens, Greece
Expert Rev Anticancer Ther 11:931-9. 2011..The study of newer targeted therapies in the treatment of bladder cancer is also discussed, as are future perspectives and a five-year view in the treatment of the disease in patients with renal impairment...
Carboplatin hypersensitivity reactions: a single institution experienceM P Zorzou
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
J Chemother 17:104-10. 2005..In conclusion, pretreatment with corticosteroids, antihistamines and a slower infusion rate may make re-treatment possible in patients having experienced hypersensitivity to carboplatin...
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experienceC A Papadimitriou
Department of Clinical Therapeutics, Alexandra Hospital, Athens University School of Medicine, Athens, Greece
Eur J Gynaecol Oncol 28:109-16. 2007..Uterine sarcomas are rare neoplasms characterized by a high rate of local recurrences and distant metastases. The role of chemotherapy in early-stage completely resected disease remains controversial...
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) studyG Mountzios
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece
Ann Oncol 20:1362-8. 2009....
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapyE Kastritis
Department of Clinical Therapeutics, Alexandra Hospital, Athens University School of Medicine, Athens, Greece
Int J Gynecol Cancer 16:994-9. 2006..Patients with isolated brain metastases have comparable survival to patients with relapse outside the CNS, and long-term remission can be achieved in some cases, provided that systemic chemotherapy is added to local treatment...
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyE Briasoulis
Ioannina University Hospital, Ioannina, Greece
Cancer Chemother Pharmacol 62:277-84. 2008..We evaluated the irinotecan-oxaliplatin combination (IROX regimen) in previously untreated patients with non-favorable subsets of unknown primary carcinomas...
DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladderC Deliveliotis
Department of Urology, Medical School, University of Athens, Athens, Greece
Urol Res 33:39-43. 2005..The results of this study suggest that DNA ploidy can provide prognostic information on patients with muscle invasive carcinoma of the bladder and might represent a means of selection for postoperative management...
Short- and long-term complications of open radical prostatectomy according to the Clavien classification systemConstantinos A Constantinides
1st University Department of Urology, Athens University Medical School, Laiko and Sismanoglio Hospital, Athens, Greece
BJU Int 103:336-40. 2009..To assess the use of the Clavien classification system in documenting the complications related to open retropubic radical prostatectomy (RRP)...
Bilateral spontaneous retroperitoneal bleeding in a patient on nimesulide: a case reportIraklis C Mitsogiannis
2nd Department of Urology, University of Athens, School of Medicine, Athens, Greece
J Med Case Rep 5:568. 2011..abstract:..
Laparoscopic urinary stone surgery: an updated evidence-based reviewAndreas Skolarikos
Department of Urology, School of Medicine, Sismanoglio Hospital, University of Athens, Athens, Greece
Urol Res 38:337-44. 2010..Laparoscopic nephrolithotomy may be indicated to remove a stone from an anterior diverticulum or when PNL or flexible ureteroscopy have failed (III/B)...
Prevention and treatment of complications following percutaneous nephrolithotomyAndreas Skolarikos
Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece
Curr Opin Urol 18:229-34. 2008..The aim of this article is to identify classification and grading systems of percutaneous nephrolithotomy-related complications and evidence for the prevention and treatment of these complications...
Training in ureteroscopy: a critical appraisal of the literatureAndreas Skolarikos
Athens Medical School, Second Department of Urology, Sismanoglio Hospital, Athens, Greece
BJU Int 108:798-805; discussion 805. 2011..Careful curriculum design in high-volume stone centres may be the key to optimizing URS training...
Problems faced by relatives caring for cancer patients at homeThomas Tsigaroppoulos
2nd Department of Urology, University of Athens, Sismanoglio Hospital, Athens, Greece
Int J Nurs Pract 15:1-6. 2009..Many of them remain undetected. The acknowledgement and recognition of these problems by health-care professionals might contribute to finding solutions in order to assist the difficult task of these individuals...
Targeting angiogenesis in renal cell carcinomaGeorgios Lainakis
Dept of Clinical Therapeutics, Medical School, University of Athens, 15235 Athens, Greece
Curr Cancer Drug Targets 8:349-58. 2008..All the agents have been proven more effective than the interferon as first or second-line treatment. This review will focus in these recent developments and the intense continuing clinical research in this field...
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2Apostolos C Ziogas
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece
Int J Cancer 130:857-64. 2012..Overall, our study shows that T cells secret VEGF and expresses VEGFR-2 upon activation. VEGF directly suppresses T cell activation via VEGF receptor type 2...
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerE Briasoulis
Medical Oncology Department, University Hospital, Ioannina, Greece
Cancer Chemother Pharmacol 56:521-8. 2005..The irinotecan-cisplatin combination has emerged as a new standard for the treatment of advanced-stage small-cell lung cancer (AS-SCLC). To move forward we developed a 3-day regimen of cisplatin, etoposide and irinotecan...
Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic modelG Mountzios
University of Athens, Medical School, Department of Clinical Therapeutics, Athens, Greece
Gynecol Oncol 108:130-5. 2008..The aim of the study was to determine the prognostic factors in RMEC after taxane-based chemotherapy...
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology GroupP A Kosmidis
Department of Medical Oncology, Hygeia Hospital, Athens, Greece
Ann Oncol 19:115-22. 2008..This phase III study was designed to compare the combination paclitaxel (Taxol)-gemcitabine (PG) versus carboplatin-gemcitabine (CG) in patients with advanced inoperable non-small-cell lung cancer...
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology GroupA Bamias
Department of Clinical Therapeutics and Urology, University of Athens, School of Medicine, Greece
J Urol 171:1467-70. 2004..4), respectively. CONCLUSIONS: Adjuvant chemotherapy with paclitaxel and carboplatin is feasible and could be used as adjuvant treatment for high risk bladder carcinoma. Its true value should be assessed in prospective, randomized trials...
The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapyA Protopapas
1st Department of Obstetrics and Gynecology of the University of Athens, School of Medicine, Alexandra Hospital, Athens, Greece
Eur J Gynaecol Oncol 25:225-9. 2004..CONCLUSION: Bcl-2 and cathepsin D expression are associated with response to CP but not TP chemotherapy. P53, bcl-2, c-erb B-2 and cathepsin D expression was not correlated with PFS and OS in our study...
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acidM A Dimopoulos
Department of Clinical Therapeutics, Medical School, University of Athens, Greece
Ann Oncol 20:117-20. 2009..We investigated whether the occurrence of ONJ decreased after the implementation of preventive measures in 128 patients with MM who received zoledronic acid...
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapyE Kastritis
Department of Clinical Therapeutics, Alexandra Hospital, Athens University School of Medicine, 31 Komninon Street, Haidari, 124 62 Athens, Greece
Gynecol Oncol 99:376-82. 2005..CONCLUSION: Our study showed a similar outcome for both squamous and non-squamous stage IV or recurrent cervical carcinomas treated with platinum-based combination chemotherapy...
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancerC S Boskos
1st Radiation Oncology Department, Agios Savvas Anticancer Institute, Athens, Greece
J Surg Oncol 102:408-12. 2010....
Sunitinib treatment in patients with severe renal function impairment: a report of four cases by the Hellenic Cooperative Oncology GroupG Lainakis
Department of Clinical Therapeutics, University of Athens, Medical School, Athens
Clin Nephrol 72:73-8. 2009..We conclude that sunitinib can be administered to the majority of patients with RCC and significant renal function impairment...
Diagnosis and management of postpercutaneous nephrolithotomy residual stone fragmentsAndreas Skolarikos
Second Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece
J Endourol 23:1751-5. 2009..While medical therapy and shockwave lithotripsy possess a minor role, second-look flexible nephroscopy and/or flexible ureterorenoscopy seem to be the treatments of choice for residual stone fragments after PCNL...
Splenogonadal fusion: report of a case and review of the literatureGerasimos Alivizatos
Second Urology Department of Athens Medical School, Athens, Greece
Int J Urol 12:90-2. 2005..Splenogonadal fusion, although a rare condition, may account for a non-malignant testicular mass and should be suspected in young patients with other congenital anomalies...
Photoselective vaporization of the prostate to manage benign prostatic hyperplasiaGerasimos Alivizatos
Second Urology Department, Athens Medical School, Sismanoglio Hospital, Athens, Greece
J Endourol 22:2117-9. 2008
Extracorporeal shock wave lithotripsy 25 years later: complications and their preventionAndreas Skolarikos
Urology Department, Athens Medical School, Sismanoglio Hospital, Athens, Greece
Eur Urol 50:981-90; discussion 990. 2006..CONCLUSION: ESWL is a safe method to treat stones when proper indications are followed. The need for well-designed prospective randomised trials on aetiology and prevention of its complications arises through the literature review...
Ureteroscopic removal of mildly migrated stents using local anesthesia onlyKostantinos E Livadas
Second Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece
J Urol 178:1998-2001. 2007..In the outpatient office setting we evaluated the feasibility and efficacy of ureteroscopic removal of upward migrated ureteral stents using local or no anesthesia...
Thalidomide and immunomodulatory drugs in the treatment of cancerAristotle Bamias
University of Athens School of Medicine, Department of Clinical Therapeutics, 227 Kifissias Avenue, Kifissia, Athens, 14561, Greece
Expert Opin Investig Drugs 14:45-55. 2005..They have already shown promising activity in multiple myeloma and are currently being evaluated in clinical studies...
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou
Department of Clinical Therapeutics, Alexandra Hospital, University of Athens School of Medicine, Athens, Greece
Bone Marrow Transplant 41:547-54. 2008..In an intent-to-treat analysis, there were no significant differences between the two arms in TTP (P=0.059) as well as in overall survival (OS) (P=0.38)...
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides
Second Department of Internal Medicine, Oncology Section, University General Hospital Attikon, Athens, Greece
Int J Gynecol Cancer 17:1003-10. 2007..001). In conclusion, younger women with EOC have significantly improved survival compared to older patients. Age, PS, stage of the disease at diagnosis, and residual disease are important independent predictors for survival...
Thalidomide in cancer medicineV Eleutherakis-Papaiakovou
Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece
Ann Oncol 15:1151-60. 2004..Limited activity was demonstrated in patients with glioma, while thalidomide appears to be inactive in patients with head and neck cancer, breast or ovarian cancer...
Late relapse of epithelial ovarian cancer: a single institution experienceA Bamias
Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece
Eur J Gynaecol Oncol 26:439-42. 2005..CONCLUSION: Late relapses of ovarian cancer occur in early stages, where they are relatively frequent, while the chemosensitivity of the disease may be less than expected...
Conservative and radiological management of simple renal cysts: a comprehensive reviewAndreas Skolarikos
Athens Medical School, 2nd Department of Urology, Sismanoglio Hospital, Athens, Greece
BJU Int 110:170-8. 2012..Simple renal cysts may not require treatment when asymptomatic. Radiological intervention with the use of sclerosants needs further evaluation and comparison with other treatment methods...
Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladderNikolaos D Melissourgos
Department of Urology, Medical Diagnosis Primary Health Care Unit, Athens, Greece
Urology 66:536-41. 2005..To investigate whether immunocytochemical detection of cytokeratin (CK)-20 could serve as a reliable diagnostic marker for transitional cell carcinoma (TCC) of the bladder...
Greenlight laser in benign prostatic hyperplasia: turning green into goldGerasimos Alivizatos
Second Department of Urology, Athens Medical School, Sismanoglio Hospital, Athens, Greece
Curr Opin Urol 18:46-9. 2008....
Solitary neurofibroma of the spermatic cordCharalampos Deliveliotis
Department of Urology, Sismanoglio Hospital, Medical School of Kapodistrian, University of Athens, Greece
Int Urol Nephrol 34:373-5. 2002..Only a little number of solitary neurofibromas of the spermatic cord are reported in the literature...
Modified ileal neobladder for continent urinary diversion: functional results after 9 years of experienceAndreas Skolarikos
2nd Department of Urology, University of Athens, Sismanoglio Hospital, Athens, Greece
J Urol 171:2298-301. 2004....
Postradical cystectomy bowel perforation caused by a drainage tube: a case reportEleftherios P Chatzidarellis
2nd Department of Urology Athens Medical School, Sismanoglio Hospital, Athens, Greece
Cases J 1:350. 2008..CASE PRESENTATION: We describe a case of perforation of the large bowel caused by the drain tube placed in a 74-year-old patient who had undergone radical cystectomy for invasive bladder cancer...
Leukocytoclastic vasculitis after long-term treatment with sunitinib: a case reportAlexandra Karadimou
Clinical Therapeutics, University of Athens, Athens, Greece
Case Rep Oncol 4:385-91. 2011..One year after the diagnosis, the patient is still on this therapy. Oncology providers should be aware of this rare but potentially serious, possible adverse effect of sunitinib...
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG)D Pectasides
2nd Department of Internal Medicine, Propaedeutic, Oncology Section, Attikon University Hospital, Rimini 1, Haidari, Athens, Greece
Anticancer Res 29:745-51. 2009..The aim of this retrospective study was to present the epidemiological, pathological and clinical characteristics and treatment results of Greek women with epithelial ovarian cancer (EOC)...
Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinomaA Bamias
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece
Urology 62:368-73. 2003..Their expression and prognostic significance after resection of renal cell carcinoma have not been adequately studied...
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis Papaiakovou
Department of Clinical Therapeutics, University of Athens, School of Medicine, Greece
Leuk Lymphoma 48:337-41. 2007..When corrected for stage, renal failure had no impact on survival...
